Intro:
India's top drug regulator has approved a study to assess if mixing two COVID-19 vaccines is feasible.
The study will include two main vaccines at the country's disposal – the Oxford AstraZenca shot and the locally developed Covaxin.
Experts say a mixed dose regimen could result in better immunogenicity, as Ishan Garg reports.
IN: The study
OUT: SOC
Duration: 45 seconds
http://www.fsnradionews.com/feeds/0811-IndiaVaccineMixing-ig-gen.mp3